| 
			1 | 
		
			
									
						Genetic and pharmacological inhibition of microRNA-92a maintains podocyte cell cycle quiescence and limits crescentic glomerulonephritis Henique, Carole. - Freiburg : Universität, 2019
					
							 | 
									
			
								
									  
								
			 | 
		
		
			
			 
			
					    					 
							
			 | 
			2 | 
		
			
									
						Genetic and pharmacological inhibition of microRNA-92a maintains podocyte cell cycle quiescence and limits crescentic glomerulonephritis Henique, Carole. - Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg, 2017
					
							 | 
									
			
								
									  
								
			 | 
		
		
			
			 
			
					    					 
							
			 | 
			3 | 
		
			
									
						Front Cover Advanced Materials 4/2012 Enthalten in Advanced engineering materials Bd. 14, 2012, Nr. 4. 1 S.
					
							 | 
									
			
								
									  
								
			 | 
		
		
			
			 
			
					    					 
							
			 | 
			4 | 
		
			
									
						Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial Enthalten in BMC cancer Bd. 20, 25.4.2020, Nr. 1, date:12.2020: 1-11
					
							 | 
									
			
								
									  
								
			 | 
		
		
			
			 
			
					    					 
							
			 | 
			5 | 
		
			
									
						DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study Enthalten in Experimental hematology & oncology Bd. 12, 21.7.2023, Nr. 1, date:12.2023: 1-5
					
							 | 
									
			
								
									  
								
			 | 
		
		
			
			 
			
					    					 
							
			 | 
			6 | 
		
			
									
						Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation Enthalten in Clinical epigenetics Bd. 11, 12.10.2019, Nr. 1, date:12.2019: 1-14
					
							 | 
									
			
								
									  
								
			 | 
		
		
			
			 
			
					    					 
							
			 | 
			7 | 
		
			
									
						Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO – PRODIGE 82) Enthalten in BMC cancer Bd. 23, 29.7.2023, Nr. 1, date:12.2023: 1-9
					
							 | 
									
			
								
									  
								
			 | 
		
		
			
			 
			
					    					 
							
			 | 
			8 | 
		
			
									
						Structure and Mechanical Performance of a “Modern” Fish Scale † ‡ Enthalten in Advanced engineering materials Bd. 14, 2012, Nr. 4: B185-B194. 10 S.
					
							 | 
									
			
								
									  
								
			 | 
		
		
			
			 
			
					    					 
							
			 | 
			9 | 
		
			
									
						Structure and Mechanical Performance of Teleost Fish Scales Enthalten in Materials Research Society: MRS online proceedings library Bd. 1420, 1.12.2011, Nr. 1, date:12.2012: 30-35
					
							 | 
									
			
								
									  
								
			 |